These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 14942529)

  • 1. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
    TOOHEY M
    Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies on the effect of dicumarol and tromexan on prothrombin level, capillary resistance and capillary permeability].
    LINKE A
    Dtsch Med Wochenschr; 1952 Jun; 77(24):775-80. PubMed ID: 14936621
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
    SCARRONE LA; BECK DF; WRIGHT IS
    Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.
    DOUGLAS AS; BROWN A
    Br Med J; 1952 Feb; 1(4755):412-5. PubMed ID: 14896166
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental and clinical results with Tromexan].
    WRIGHT IS; BURKE GE; SCARONE LA
    Med Welt (Stuttg); 1951 Nov; 20(47):1469-71. PubMed ID: 14910281
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with the anticoagulant, tromexan.
    BRONSTEIN MR; WITKIND E
    Am J Med Sci; 1951 Dec; 222(6):677-85. PubMed ID: 14885211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
    DELLA SANTA R
    Helv Med Acta Suppl; 1952; 19(28):1-64. PubMed ID: 13044126
    [No Abstract]   [Full Text] [Related]  

  • 12. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 13. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 15. Tromexan and dicoumarol.
    ILLINGWORTH DG
    Br Med J; 1951 Sep; 2(4732):646-8. PubMed ID: 14869675
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of prothrombin determination; comparative studies with the one- and two-phase method in the control of the dicoumarin medication].
    ARNOLDS P; ERLEMANN E
    Klin Wochenschr; 1952 Jan; 30(1-2):22-5. PubMed ID: 14939638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulant therapy with tromexan].
    GARCIA TURIELLA R; GASPARY FV; TUERO PR; FERRER J
    Prensa Med Argent; 1953 Aug; 40(32):2093-2103. PubMed ID: 13088693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticoagulant therapy; tromexan and G-23350].
    MAROIS A; BROSSEAU C
    Laval Med; 1955 Sep; 20(7):940-51. PubMed ID: 13279212
    [No Abstract]   [Full Text] [Related]  

  • 19. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 20. [SKIN NECROSES IN ANTICOAGULANT THERAPY].
    STACHER A
    Wien Z Inn Med; 1964 Feb; 45():47-9. PubMed ID: 14155957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.